BioSpace News Archive

Ambu has reached an agreement with Ives EEG Solutions LLC to be the exclusive U.S. distributor of its MRI-compatible single-use electroencephalogram (EEG) cup electrodes.

AMN Healthcare (NYSE:AMN), the leader and innovator in workforce solutions and healthcare staffing services, recognizes the valuable contributions of its top affiliates to AMN Managed Services Programs (MSP), which provide comprehensive management of contingent staffing to healthcare systems.

Diamyd Medical announced today, when all 12 patients have been followed throughout the 30-month period in the open-label trial DIAGNODE-1, that the patients show on average a positive clinical course with a near normal long-term blood sugar and a low need for externally supplied insulin.

The U.S. Food and Drug Administration and the Drug Enforcement Administration (DEA) announced today that they have seized 44 websites advertising the sale of illicit vaping cartridges containing tetrahydrocannabinol (THC), the primary psychoactive component of the cannabis plant.

Emergent BioSolutions Inc. (NYSE: EBS) today announced that two members of its board of directors – Dr. Sue Bailey and Dr. Kathryn C. Zoon – have been recognized as WomenInc. magazine’s 2019 Most Influential Corporate Directors.

United Health Products (UHP) (OTCPK: UEEC) today announced that 2019 was a pivotal year for the company in which it:

OncoSec Medical Incorporated (NASDAQ:ONCS), (the “Company” or “OncoSec”) today issued the following response to the latest press release from Alpha Holdings, Inc. (Alpha):

The medical providers at HeadFirst Sports Injury and Concussion Care, the premier community concussion clinic for the diagnosis, management, and treatment of mild traumatic brain injuries (TBI), are offering tips for getting through the holidays while recovering from a head injury.

Veterinary Care, Inc., d/b/a VitalPet, recently in chapter 11 proceedings in the Southern District of Texas, announced it has secured interim DIP financing in the amount of $5.5 million from VP Senior LLC, its pre-petition senior secured lender.

XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the closing of its previously announced rights offering (the “Rights Offering”). At the closing, XOMA sold and issued an aggregate of 626,805 shares of its common stock (the “Common Stock”) pursuant to the exercise of subscriptions in the Rights Offering from its existing stockholders.